Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy)

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 4, 1996, Pages 245-250

  D'Amato, G ^a   Liccardi, G ^a   Russo, M ^a   Saggese, M ^a   D'Amato, M ^a  

^a CARDARELLI HOSPITAL   (Italy)

Author keywords

bronchial hyperresponsiveness; ECP; immunotherapy; pollinosis; respiratory allergy; seasonal allergy

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; POLLEN EXTRACT;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOTHERAPY; INFLAMMATION; MALE; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; SEASONAL VARIATION; SENSITIZATION; SKIN TEST; TREATMENT OUTCOME;

EID: 0029997991     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04600.x     Document Type: Article

References (43)

1. Burney PGJ. Evidence for an increase in atopic disease and possible causes. Clin Exp Allergy 1993;23:484-92.
2. Corbo GM, Forastiere F, Dell'Orco V, et al. Effects of environment on atopic status and respiratory disorders in children. J Allergy Clin Immunol 1993;92:616-23.
3. D'Amato G, Liccardi G, Cazzola M. Environment and development of respiratory allergy. I Outdoor. Monaldi Arch Chest Dis 1994;49:406-11.
4. Wüthrich B. In Switzerland pollinosis has really increased in the last decades. ACI News 1991;3:41-4.
5. D'Amato G, Lobefalo G. Allergenic pollens in the Mediterranean area. J Allergy Clin Immunol 1989; 83:116-22.
6. D'Amato G, Liccardi G, Melillo G. A study on airborne allergenic pollen content of the atmosphere of Naples. Clin Allergy 1983;13:537-44.
7. D'Amato G, Dal Bo S, Bonini S. Pollen-related allergy in Italy. Ann Allergy 1992;68:433-7.
8. D'Amato G, Liccardi G. Pollen-related allergy in the European Mediterranean area. Clin Exp Allergy 1994; 24:210-19.
9. D'Amato G, Ruffilli A, Ortolani C. Allergenic significance of Parietaria (pellitory-of-the-wall) pollen. In: D'Amato G, Spieksma FThM, Bonini S, editors. Allergenic pollen and pollinosis in Europe. Oxford: Blackwell Scientific, 1991:111-16.
10. Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel FB. Eosinophilic inflammation in asthma. Am J Respir Crit Care Med 1994;150 (Suppl):S33-8.
11. Bousquet J, van Vyve T, Chanez P, Enander I, Michel FB, Godard P. Cells and mediators in bronchoalveolar lavage of asthmatic patients - the example of eosinophilic inflammation. Allergy 1993;48:70-6.
12. D'Amato G. Patologia allergica respiratoria. Milan: Kurtis, 1993.
13. Kay AB. Biological properties of eosinophils. Clin Exp Allergy 1991;21 Suppl 3:23-9.
14. Rossi GA, Crimi E, Lantero S, et al. Late phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. Am Rev Respir Dis 1991;144:379-83.
15. Venge P, Håkansson L, Peterson CGB. Eosinophil activation in allergic disease. Int Arch Allergy Appl Immunol 1987;82:333-8.
16. Rak S. Effects of immunotherapy on the inflammation in pollen asthma. Allergy 1993;48:125-8.
17. Rak S, Björnson A, Håkansson L, Sorenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991;88:878-8.
18. European Academy of Allergology and Clinical Immunology. Position paper of the Subcommittee on Skin tests. Skin tests used in type I allergy testing. Allergy 1989;10:1-59.
19. Fabbri LM, Mapp CE, Hendrick DS. Standardization of the dosimeter method for measurement of airway responsiveness in man. In: Hargreave FE, Woodcock AS. editors. Airway responsiveness. Mont St Marie, Ambec: Astra Pharmaceutical Canada Ltd, 1985:29-34.
20. Bousquet J, Chanez P, Lacoste JY, et al. Indirect evidence of bronchial inflammation assessed by titration of inflammatory mediators in BAL fluid of patients with asthma. J Allergy Clin Immunol 1991;88:649-60.
21. Coyle AJ, Uchida D, Ackerman SJ, Mitzner W, Irvin CG. Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am J Respir Crit Care Med 1994;150 Suppl:S63-S71.
22. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991;87:893-910.
23. Kay AB, Nadel JA, Heuson PM, Irvin CG, Hunninghake GW, Lichtenstein LM. The role of inflammatory cells and their mediators in bronchial hyperresponsiveness. In: Holgate ST, editor. The role of inflammatory processes in airways hyperresponsiveness. London: Blackwell, 1989:151-78.
24. Plaits-Mills TAE. Mechanisms of bronchial reactivity - the role of immunoglobulin E. Am Rev Respir Dis 1992;145 Suppl:S44-7.
25. Plans-Mills TAE, Pollart S, Chapman MD, Luczynska CM. The role of allergens in asthma and airway hyperresponsiveness - relevance to immunotherapy and allergen avoidance. In: Kaliner M, Barnes P, Persson C, editors. Pharmacology and pathophysiology of airway hyperresponsiveness. New York: Marcel Dekker, 1991:595-631.
26. Sporik R, Holgate ST, Platts-Mills TAE, Cogswell JJ. Exposure to house dust mite allergens (Der p I) and the development of asthma in children. N Engl J Med 1990; 323:502-7.
27. Charpin D, Hughes B, Mallea M, et al. Seasonal allergic symptoms and their relation to pollen exposure in southeast France. Clin Exp Allergy 1993;23:435-9.
28. Pollart SM, Chapman MD, Fiocco GP, et al. Epidemiology of acute asthma. IgE antibodies to common inhalant allergens as a risk factor for emergency room visits. J Allergy Clin Immunol 1989;83:875-82.
29. D'Amato G, Ruffilli A, Sacerdoti G, Bonini S. Parietaria pollinosis: a review. Allergy 1992;47:443-9.
30. Dahl R. Monitoring bronchial asthma in the blood. Allergy 1993;48:77-80.
31. Hargreave FE, Popov T, Kidney J, Dolovich J. Sputum measurements to assess airway inflammation in asthma. Allergy 1993;48:81-3.
32. Holgate ST, Wilson JR, Howart PH. New insights into airway inflammation by endobronchial biopsy. Am Rev Respir Dis 1992;145 Suppl:S1-S6.
33. Howarth PH, Bradding P, Montefort S, et al. Mucosal inflammation in asthma. Am J Respir Crit Care Med 1994;150 Suppl:S18-S22.
34. Moqbel R, Barkans J, Bradley BL, Durham SR, Kay AB. Application of monoclonal antibodies against major basic protein (BMK-13) and eosinophil cationic protein (EG1 and EG2) for quantifying eosinophils in bronchial biopsies from atopic asthma. Clin Exp Allergy 1992;22:265-73.
35. Motojima S, Akutsu I, Fukuda T, Makino S, Takatsu K. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 1993;48:98-106.
36. Sugai T, Sakiyama Y, Matumoto S. Eosinophil cationic protein in peripheral blood of pediatric patients with allergic diseases. Clin Exp Allergy 1992;22:275-81.
37. Zimmerman B. Clinical experience with the measurement of ECP - usefulness in the management of children with asthma. Clin Exp Allergy 1993;23 Suppl 2:8-12.
38. Bousquet J, Michel FB. Specific immunotherapy in asthma is it effective? J Allergy Clin Immunol 1994;94:1-11.
39. BSACI. Position paper on Immunotherapy. Clin Exp Allergy 1993;23:1-44.
40. Durham SR, Varney V, Gaga M, Frew AJ, Jacobson M, Kay AB. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991;21 Suppl 1:206-10.
41. Mailing H-J, Weeke B. EAACI immunotherapy position paper. Allergy 1993;48:9-35.
42. Mailing H-J. Immunotherapy in Europe. Clin Exp Allergy 1994;24:515-21.
43. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988;82:470-80.